Stefan Leucht
Stefan Leucht
Prof. Dr. med., Klinik für Psychiatrie und Psychotherapie der TU-München
Bestätigte E-Mail-Adresse bei lrz.tum.de
Titel
Zitiert von
Zitiert von
Jahr
Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis
S Leucht, C Corves, D Arbter, RR Engel, C Li, JM Davis
The Lancet 373 (9657), 31-41, 2009
20552009
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
S Leucht, A Cipriani, L Spineli, D Mavridis, D Örey, F Richter, M Samara, ...
The Lancet 382 (9896), 951-962, 2013
19772013
Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care
M De Hert, CU Correll, J Bobes, M Cetkovich-Bakmas, DAN Cohen, I Asai, ...
World psychiatry 10 (1), 52, 2011
17442011
Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A …
S Leucht, G Pitschel-Walz, D Abraham, W Kissling
Schizophrenia research 35 (1), 51-68, 1999
10401999
Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis
A Cipriani, TA Furukawa, G Salanti, A Chaimani, LZ Atkinson, Y Ogawa, ...
Focus 16 (4), 420-429, 2018
9972018
What does the PANSS mean?
S Leucht, JM Kane, W Kissling, J Hamann, E Etschel, RR Engel
Schizophrenia research 79 (2-3), 231-238, 2005
8722005
The effect of family interventions on relapse and rehospitalization in schizophrenia—a meta-analysis
G Pitschel-Walz, S Leucht, J Bäuml, W Kissling, RR Engel
Schizophrenia bulletin 27 (1), 73-92, 2001
8612001
Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies
CU Correll, S Leucht, JM Kane
American Journal of psychiatry 161 (3), 414-425, 2004
8192004
Opioid antagonists for alcohol dependence
S Roesner, A Hackl‐Herrwerth, S Leucht, S Vecchi, M Srisurapanont, ...
Cochrane database of systematic reviews, 2010
8032010
Physical illness and schizophrenia: a review of the literature
S Leucht, T Burkard, J Henderson, M Maj, N Sartorius
Acta Psychiatrica Scandinavica 116 (5), 317-333, 2007
7532007
Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis
S Leucht, M Tardy, K Komossa, S Heres, W Kissling, G Salanti, JM Davis
The Lancet 379 (9831), 2063-2071, 2012
7292012
Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level
M De Hert, DAN Cohen, J Bobes, M Cetkovich-Bakmas, S Leucht, ...
World psychiatry 10 (2), 138, 2011
7212011
New generation antipsychotics versus low-potency conventional antipsychotics: a systematic review and meta-analysis
S Leucht, K Wahlbeck, J Hamann, W Kissling
The Lancet 361 (9369), 1581-1589, 2003
7112003
Clinical implications of brief psychiatric rating scale scores
S Leucht, JM Kane, W Kissling, J Hamann, EVA Etschel, R Engel
The British Journal of Psychiatry 187 (4), 366-371, 2005
6492005
Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: a systematic review and meta-analysis
C Rummel-Kluge, K Komossa, S Schwarz, H Hunger, F Schmid, ...
Schizophrenia research 123 (2-3), 225-233, 2010
6452010
Relapse prevention in schizophrenia with new-generation antipsychotics: a systematic review and exploratory meta-analysis of randomized, controlled trials
S Leucht, TRE Barnes, W Kissling, RR Engel, C Correll, JM Kane
American Journal of Psychiatry 160 (7), 1209-1222, 2003
6322003
A meta-analysis of head-to-head comparisons of second-generation antipsychotics in the treatment of schizophrenia
S Leucht, K Komossa, C Rummel-Kluge, C Corves, H Hunger, F Schmid, ...
American Journal of Psychiatry 166 (2), 152-163, 2009
5912009
Why olanzapine beats risperidone, risperidone beats quetiapine, and quetiapine beats olanzapine: an exploratory analysis of head-to-head comparison studies of second-generation …
S Heres, J Davis, K Maino, E Jetzinger, W Kissling, S Leucht
American Journal of Psychiatry 163 (2), 185-194, 2006
5542006
The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary
JM Kane, S Leucht, D Carpenter, JP Docherty
Journal of Clinical Psychiatry 64 (Suppl 12), 5-19, 2003
514*2003
How effective are second-generation antipsychotic drugs? A meta-analysis of placebo-controlled trials
S Leucht, D Arbter, RR Engel, W Kissling, JM Davis
Molecular psychiatry 14 (4), 429-447, 2009
5112009
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20